Wall Street Zen upgrades DaVita stock to Buy

Published on 10/20/2026 at 20:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 3.55 billion, up 5.20 percent year over year. DaVita stock costs EUR 155.30 on October 20, 2026.

Analyst view turns positive

Wall Street Zen upgraded DaVita from Hold to Buy on October 17, 2026.
Second-quarter revenue reached USD 3.55 billion, up 5.20 percent year over year.
DaVita stock costs EUR 155.30 at Lang & Schwarz on October 20, 2026 at 8:20 p.m. CEST.
DaVita plans to release third-quarter results on October 29, 2026.

Schwarzweiß-Reportagefoto eines Dialysepatienten mit Pflegekraft in Klinikumgebung — Dokumentarische Schwarzweiß-Aufnahme eines Dialysepatienten der DaVita Inc. mit Pflegekraft beim Behandeln, ISIN US23918K1088, Illustration mit AI erstellt.

DaVita Inc. (ISIN US23918K1088) received a Hold-to-Buy upgrade from Wall Street Zen on October 17, 2026, according to MarketBeat. The stock was trading at EUR 155.30 at Lang & Schwarz on October 20, 2026 at 8:20 p.m. CEST.

The upgrade adds a new signal

Wall Street Zen's latest rating differs from the broader seven-analyst consensus, which MarketBeat described as Moderate Buy on October 13, 2026. Four analysts rated DaVita Buy and three rated it Hold, while the average 12-month target stood at USD 233.43.

The target was published before the current euro quotation and uses the NYSE listing in USD. It therefore provides a separate reference for investor expectations rather than a direct comparison with the Lang & Schwarz price.

Second-quarter results set the baseline

DaVita generated USD 3.55 billion of revenue in the second quarter of 2026, 5.20 percent above the prior-year quarter, while net income reached USD 265.40 million. The figures were reported by EarningsStory from the period ended June 30, 2026.

Operating cash flow for the first six months of 2026 reached USD 811.00 million, compared with USD 504.00 million in the same period of 2025. That increase gives the rating change a financial backdrop, although reimbursement mix, labor costs and collections remain important operating variables.

October 29 is the next test

DaVita announced on October 19, 2026 that it plans to release third-quarter results after the market close on October 29, 2026, followed by a conference call at 5:00 p.m. Eastern Time. The date and schedule were published in the company's newsroom release by DaVita.

The upcoming report will give investors a fresh test of revenue growth, earnings conversion and cash generation after the second quarter's stronger operating cash flow. It will also show whether the recent analyst optimism is supported by new company figures.

NYSE valuation remains separate

On the NYSE, DaVita was last at USD 174.03 on October 20, 2026 at 2:25 p.m. Eastern Time. The stock's market capitalization was USD 11.1 billion on that date, while the reported 52-week NYSE range was USD 101.00 to USD 247.49.

For investors in Germany, the Lang & Schwarz quotation is the direct euro-denominated market view. The NYSE figures provide additional context, but the currencies and venues should not be combined in one performance calculation.